Dyslipidemia Grants

Federal Services Junior Investigator Research Grant
Supported by Abbott
Application Available: May 1, 2008
Application Deadline: January 9, 2009

Description
The Federal Services Junior Investigator Research Grant Program supports research efforts critical to the study of medication adherence and persistence in older patients who receive care through the Veterans Administration, the Department of Defense, and the Public Health Service. These medication adherence and persistence studies should focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease. A secondary goal of the program is to develop and strengthen the skills of newer researchers in the federal services and foster mentoring of these researchers by more experienced senior investigators.

Applications for this research grant program should emphasize study objectives that focus on optimal medication outcomes, sound research methods that support the study objectives, interdisciplinary collaborations, the potential for the project to be replicated in other federal health systems, and prudent use of grant funds.

Eligibility Criteria
The research must focus on the topic area. The proposed research must be conducted in a Veterans Administration, Department of Defense, or Public Health Service facility. The principal investigator for the project must be a licensed pharmacist, physician, or nurse. The principal investigator must be a new researcher within 5 years of completion of his/her terminal degree or postgraduate training or have professional experience greater than 5 years and no more than two externally funded research projects as a principal investigator. The senior investigator must be a licensed pharmacist, physician, or nurse. The proposed research must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval or evidence of exemption from IRB review has been received. The research must comply with the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research. The study timeline should not exceed 2 years beyond project initiation.

Funding Information
Two $25,000 grants will be awarded. Grants are awarded to junior investigators to provide funding for research related to medication adherence and persistence studies that focus on individuals with either autoimmune diseases, dyslipidemia, HIV/AIDS, psychiatric disorders, or stages 3 and 4 renal disease and are not intended for long-term support of research programs. One-third of the total grant will be provided with the notice of the award. One-third will be provided following receipt of a written progress report submitted at the midpoint of the timeline for study completion. The remaining one-third will be provided upon receipt of a final report that is due within 60 days of project completion.

Application Process
Pharmacists, physicians, and nurses interested in applying for funding should refer to the request for proposals and application instructions for full eligibility requirements and application procedures. Please check the Programs Calendar periodically for information about future offerings.

Selection Criteria
Grant applications will be judged by a selection panel using the following criteria:

• Rationale-10 points
• Significance-10 points
• Hypothesis/Objectives-20 points
• Study Methods-40 points
• Project Scope and Timeline-5 points
• Personnel and Facilities-15 points

Deadlines
Deadline: January 9, 2009

American Society of Health-System Pharmacists (ASHP) Research and Education Foundation
7272 Wisconsin Avenue
Bethesda, Maryland 20814
Phone: (301) 664-8612
Fax: (301) 634-5712
E-mail: foundation@ashp.org
Web site: www.ashpfoundation.org